Key facts
- This page summarizes Douglas E. Williams's Form 4 filing for Camp4 Therapeutics Corp (CAMP).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 19 Mar 2025, 16:09.
Douglas E. Williams - 17 Mar 2025 Form 4 Insider Report for Camp4 Therapeutics Corp (CAMP)
- Reporting relationship
- Director
- Issuer ticker
- CAMP
- Reported as of
- 17 Mar 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 19 Mar 2025, 16:09:30 UTC
- Prior SEC filing
- 12 Nov 2024
- Next SEC filing
- 01 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Josh Mandel-Brehm, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Douglas E. Williams filed Form 4 for Camp4 Therapeutics Corp (CAMP) on 19 Mar 2025.
Change
- Previous filing in this sequence was filed on 12 Nov 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CAMP
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +17,787
- Change %
- Price
- $0.000000
- Shares after
- 17,787
- Date
- 17 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 17,787
- Exercise price
- $5.37
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The shares underlying the option vest in equal monthly installments over a period of three years commencing from the date of grant.